PHILADELPHIA, April 10, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Sage Therapeutics, Inc. (NASDAQ: SAGE) (“Sage”) on behalf of the company’s long-term investors. Click here for additional information: https://kaskelalaw.com/case/sage-therapeutics/ Recently a securities fraud complaint was filed against Sage on behalf of certain investors who purchased or acquired shares of the company’s stock between April 12, 2021 and July 23, 2024 (the “Class Period”). According to the co ...